Literature DB >> 34047754

Socioeconomic Inequality in Respiratory Health in the US From 1959 to 2018.

Adam W Gaffney1,2, David U Himmelstein1,2,3, David C Christiani2,4, Steffie Woolhandler1,2,3.   

Abstract

Importance: Air quality has improved and smoking rates have declined over the past half-century in the US. It is unknown whether such secular improvements, and other policies, have helped close socioeconomic gaps in respiratory health. Objective: To describe long-term trends in socioeconomic disparities in respiratory disease prevalence, pulmonary symptoms, and pulmonary function. Design, Setting, and Participants: This repeated cross-sectional analysis of the nationally representative National Health and Nutrition Examination Surveys (NHANES) and predecessor surveys, conducted from 1959 to 2018. included 160 495 participants aged 6 to 74 years. Exposures: Family income quintile defined using year-specific thresholds; educational attainment. Main Outcomes and Measures: Trends in socioeconomic disparities in prevalence of current/former smoking among adults aged 25 to 74 years; 3 respiratory symptoms (dyspnea on exertion, cough, and wheezing) among adults aged 40 to 74 years; asthma stratified by age (6-11, 12-17, and 18-74 years); chronic obstructive pulmonary disease ([COPD] adults aged 40-74 years); and 3 measures of pulmonary function (forced expiratory volume in 1 second [FEV1], forced vital capacity [FVC], and FEV1/FVC<0.70) among adults aged 24 to 74 years.
Results: Our sample included 160 495 individuals surveyed between 1959 and 2018: 27 948 children aged 6 to 11 years; 26 956 children aged 12 to 17 years; and 105 591 adults aged 18 to 74 years. Income- and education-based disparities in smoking prevalence widened from 1971 to 2018. Socioeconomic disparities in respiratory symptoms persisted or worsened from 1959 to 2018. For instance, from 1971 to 1975, 44.5% of those in the lowest income quintile reported dyspnea on exertion vs 26.4% of those in the highest quintile, whereas from 2017 to 2018 the corresponding proportions were 48.3% and 27.9%. Disparities in cough and wheezing rose over time. Asthma prevalence rose for all children after 1980, but more sharply among poorer children. Income-based disparities in diagnosed COPD also widened over time, from 4.5 percentage points (age- and sex-adjusted) in 1971 to 11.3 percentage points from 2013 to 2018. Socioeconomic disparities in FEV1 and FVC also increased. For instance, from 1971 to 1975, the age- and height-adjusted FEV1 of men in the lowest income quintile was 203.6 mL lower than men in the highest quintile, a difference that widened to 248.5 mL from 2007 to 2012 (95% CI, -328.0 to -169.0). However, disparities in rates of FEV1/FVC lower than 0.70 changed little. Conclusions and Relevance: Socioeconomic disparities in pulmonary health persisted and potentially worsened over the past 6 decades, suggesting that the benefits of improved air quality and smoking reductions have not been equally distributed. Socioeconomic position may function as an independent determinant of pulmonary health.

Entities:  

Mesh:

Year:  2021        PMID: 34047754      PMCID: PMC8261605          DOI: 10.1001/jamainternmed.2021.2441

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   44.409


  44 in total

1.  Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey.

Authors:  Deidre Crocker; Clive Brown; Ronald Moolenaar; Jeanne Moorman; Cathy Bailey; David Mannino; Fernando Holguin
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

2.  Racial and ethnic disparities in current asthma and emergency department visits: findings from the National Health Interview Survey, 2001-2010.

Authors:  Emeka Oraka; Shahed Iqbal; W Dana Flanders; Kimberly Brinker; Paul Garbe
Journal:  J Asthma       Date:  2013-05-08       Impact factor: 2.515

3.  Air Pollution and Mortality in the Medicare Population.

Authors:  Qian Di; Yan Wang; Antonella Zanobetti; Yun Wang; Petros Koutrakis; Christine Choirat; Francesca Dominici; Joel D Schwartz
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 91.245

4.  Why does lung function predict mortality? Results from the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Martin Shipley; Alexis Elbaz; Michael Marmot; Mika Kivimaki; Francine Kauffmann; Archana Singh-Manoux
Journal:  Am J Epidemiol       Date:  2010-10-20       Impact factor: 4.897

5.  US racial/ethnic disparities in childhood asthma emergent health care use: National Health Interview Survey, 2013-2015.

Authors:  Audrey Urquhart; Philippa Clarke
Journal:  J Asthma       Date:  2019-04-08       Impact factor: 2.515

6.  Neighborhood poverty, urban residence, race/ethnicity, and asthma: Rethinking the inner-city asthma epidemic.

Authors:  Corinne A Keet; Meredith C McCormack; Craig E Pollack; Roger D Peng; Emily McGowan; Elizabeth C Matsui
Journal:  J Allergy Clin Immunol       Date:  2015-01-20       Impact factor: 10.793

7.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Authors:  Anne Case; Angus Deaton
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

8.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.

Authors:  D M Mannino; A S Buist; T L Petty; P L Enright; S C Redd
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

9.  Respiratory symptoms and long-term cardiovascular mortality.

Authors:  Anne Frostad; Vidar Soyseth; Tor Haldorsen; Aage Andersen; Amund Gulsvik
Journal:  Respir Med       Date:  2007-08-06       Impact factor: 3.415

Review 10.  Health, wealth, and air pollution: advancing theory and methods.

Authors:  Marie S O'Neill; Michael Jerrett; Ichiro Kawachi; Jonathan I Levy; Aaron J Cohen; Nelson Gouveia; Paul Wilkinson; Tony Fletcher; Luis Cifuentes; Joel Schwartz
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

View more
  6 in total

1.  Prognostic implications of differences in forced vital capacity in black and white US adults: Findings from NHANES III with long-term mortality follow-up.

Authors:  Adam W Gaffney; Danny McCormick; Steffie Woolhandler; David C Christiani; David U Himmelstein
Journal:  EClinicalMedicine       Date:  2021-08-20

2.  Error in Sample Size.

Authors: 
Journal:  JAMA Intern Med       Date:  2021-07-01       Impact factor: 21.873

3.  Characterizing phenotypic abnormalities associated with high-risk individuals developing lung cancer using electronic health records from the All of Us researcher workbench.

Authors:  Jie Na; Nansu Zong; Chen Wang; David E Midthun; Yuan Luo; Ping Yang; Guoqian Jiang
Journal:  J Am Med Inform Assoc       Date:  2021-10-12       Impact factor: 7.942

4.  Reply: Trends in Smoking Prevalence and the Continuing Imperative of Tobacco Control.

Authors:  Adam Gaffney; David U Himmelstein; Steffie Woolhandler
Journal:  Ann Am Thorac Soc       Date:  2022-08

5.  Healthcare disparities for the development of airway stenosis from the medical intensive care unit.

Authors:  Clayton Prakash Burruss; Robin B Pappal; Michael A Witt; Christopher Harryman; Syed Z Ali; Matthew L Bush; Mark A Fritz
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-13

6.  Full Coverage of COVID-19-related Care Was Necessary, but Do Other Pulmonary Patients Deserve Any Less?

Authors:  Adam W Gaffney
Journal:  Ann Am Thorac Soc       Date:  2022-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.